Document:

THIS COMMON STOCK PURCHASE WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 ACT, AS AMENDED (THE "1933 ACT")

THIS COMMON STOCK PURCHASE WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 ACT, AS AMENDED (THE "1933 ACT"). THE HOLDER HEREOF, BY PURCHASING THIS COMMON STOCK PURCHASE WARRANT, AGREES FOR THE BENEFIT OF THE COMPANY THAT SUCH SECURITIES MAY BE OFFERED, SOLD OR OTHERWISE TRANSFERRED ONLY (A) TO THE COMPANY, (B) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE 1933 ACT, OR (C) IF REGISTERED UNDER THE 1933 ACT AND ANY APPLICABLE STATE SECURITIES LAWS. IN ADDITION, A SECURITIES PURCHASE AGREEMENT ("PURCHASE AGREEMENT"), DATED THE DATE HEREOF, A COPY OF WHICH MAY BE OBTAINED FROM THE COMPANY AT ITS PRINCIPAL EXECUTIVE OFFICE, CONTAINS CERTAIN ADDITIONAL AGREEMENTS AMONG THE PARTIES, INCLUDING, WITHOUT LIMITATION, PROVISIONS WHICH LIMIT THE EXERCISE RIGHTS OF THE HOLDER AND SPECIFY MANDATORY REDEMPTION OBLIGATIONS OF THE COMPANY.

---------------------------------------

CORDIA CORPORATION

COMMON STOCK PURCHASE WARRANT B

Number of shares:   750,000                

Holder: Barron Partners LP

                                    

c/o Andrew Barron Worden

Managing Partner

730 Fifth Avenue, 9th Floor

New York NY 10019

tel 212-659-7790

fax 646-607-2223

cell 917-854-0036

abw@barronpartners.com

 

Expiration Date:    March 3, 2009   

                                              

Exercise Price per Share:  $4.00

Cordia Corporation, a company organized and existing under the laws of the State of Nevada (the “Company”), hereby certifies that, for value received, Barron Partners LP, or its registered assigns (the “Warrant Holder”), is entitled, subject to the terms set forth below, to purchase from the Company an aggregate of 750,000 shares (the “Warrant Shares”) of common stock, $0.001 par value (the “Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”).  Warrant Holder is entitled to purchase 750,000 shares of common stock in exchange for (a) one (1) Warrant and (b) $4.00 per share (as adjusted from time to time as provided in Section 7, per Warrant Share (the “Exercise Price”) at any time and from time to time from and after the date thereof and through and including 5:00 p.m. New York City time on March 3, 2009 (or eighteen months of effectiveness of a Registration Statement subsequent to the issuance herein, whichever is longer)(the “Expiration Date”), and subject to the following terms and conditions

1.

Registration of Warrant.  The Company shall register this Warrant upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Warrant Holder hereof from time to time.  The Company may deem and treat the registered Warrant Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Warrant Holder, and for all other purposes, and the Company shall not be affected by notice to the contrary.

2.

Investment Representation.  The Warrant Holder by accepting this Warrant represents that the Warrant Holder is acquiring this Warrant for its own account or the account of an affiliate for investment purposes and not with the view to any offering or distribution and that the Warrant Holder will not sell or otherwise dispose of this Warrant or the underlying Warrant Shares in violation of applicable securities laws.  The Warrant Holder acknowledges that the certificates representing any Warrant Shares will bear a legend indicating that they have not been registered under the United States Securities Act of 1933, as amended (the “1933 Act”) and may not be sold by the Warrant Holder except pursuant to an effective registration statement or pursuant to an exemption from registration requirements of the 1933 Act and in accordance with federal and state securities laws.  If this Warrant was acquired by the Warrant Holder pursuant to the exemption from the registration requirements of the 1933 Act afforded by Regulation S thereunder, the Warrant Holder acknowledges and covenants that this Warrant may not be exercised by or on behalf of a Person during the one year distribution compliance period (as defined in Regulation S) following the date hereof.  “Person” means an individual, partnership, firm, limited liability company, trust, joint venture, association, corporation, or any other legal entity.

3.

Validity of Warrant and Issue of Shares.  The Company represents and warrants that this Warrant has been duly authorized and validly issued and warrants and agrees that all of Common Stock that may be issued upon the exercise of the rights represented by this Warrant will, when issued upon such exercise, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issue thereof.  The Company further warrants and agrees that during the period within which the rights represented by this Warrant may be exercised, the Company will at all times have authorized and reserved a sufficient number of Common Stock to provide for the exercise of the rights represented by this Warrant.

4.

Registration of Transfers and Exchange of Warrants.

a. Subject to compliance with the legend set forth on the face of this Warrant the Company shall register the transfer of any portion of this Warrant in the Warrant in the Warrant Register, upon surrender of this Warrant with the Form of Assignment attached hereto duly completed and signed, to the Company at the office specified in or pursuant to Section 12.  Upon any such registration or transfer, a new warrant to purchase Common Stock, in substantially the form of this Warrant (any such new warrant, a “New Warrant”), evidencing the portion of this Warrant so transferred shall be issued to the transferee and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Warrant Holder.  The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance of such transferee of all of the rights and obligations of a Warrant Holder of a Warrant.

b. This Warrant is exchangeable, upon the surrender hereof by the Warrant Holder to the office of the Company specified in or pursuant to Section 11 for one or more New Warrants, evidencing in the aggregate the right to purchase the number of Warrant Shares which may then be purchased hereunder.  Any such New Warrant will be dated the date of such exchange.

5.

Exercise of Warrants.

a.  Upon surrender of this Warrant with the Form of Election to Purchase attached hereto duly completed and signed to the Company, at its address set forth in Section 12, and upon payment and delivery of the Exercise Price per Warrant Share multiplied by the number of Warrant Shares that the Warrant Holder intends to purchase hereunder, in lawful money of the United States of America, in cash or by certified or official bank check or checks, to the Company, all as specified by the Warrant Holder in the Form of Election to Purchase, the Company shall promptly (but in no event later than 7 business days after the Date of Exercise [as defined herein]) issue or cause to be issued  and cause to be delivered to or upon the written order of the Warrant Holder and in such name or names as the Warrant Holder may designate (subject to the restrictions on transfer described in the legend set forth on the face of this Warrant), a certificate for the Warrant Shares issuable upon such exercise, with such restrictive legend as required by the 1933 Act.  Any person so designated by the Warrant Holder to receive Warrant Shares shall be deemed to have become holder of record of such Warrant Shares as of the Date of Exercise of this Warrant.

b.  A “Date of Exercise” means the date on which the Company shall have received (i) this Warrant (or any New Warrant, as applicable), with the Form of Election to Purchase attached hereto (or attached to such New Warrant) appropriately completed and duly signed, and (ii) payment of the Exercise Price for the number of Warrant Shares so indicated by the Warrant Holder to be purchased.

c.  This Warrant shall be exercisable at any time and from time to time for such number of Warrant Shares as is indicated in the attached Form of Election To Purchase.  If less than all of the Warrant Shares which may be purchased under this Warrant are exercised at any time, the Company shall issue or cause to be issued, at its expense, a New Warrant evidencing the right to purchase the remaining number of Warrant Shares for which no exercise has been evidenced by this Warrant.

d.  (i)  Notwithstanding anything contained herein to the contrary, the holder of this Warrant may, at its election exercised in its sole discretion exercise this Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the Aggregate Exercise Price, elect instead to receive upon such exercise the “Net Number” of shares of Common Stock determined according to the following formula (a “Cashless Exercise”):

Net Number = (A x (B - C))/B

(ii)  For purposes of the foregoing formula:

 

A= the total number shares with respect to which this Warrant is then being exercised.

 

B= the last reported sale price (as reported by Bloomberg) of the Common Stock on immediately preceding the date of the Exercise Notice.

 

C= the Warrant Exercise Price then in effect at the time of such exercise.

a.

The holder of this Warrant agrees not to elect for a period of one (1) 

year a Cashless Exercise. The holder of this Warrant also agrees not to elect a Cashless Exercise so long as there is an effective registration statement for the shares underlying this Warrant.

1.

Maximum Exercise.  The Warrant Holder shall not be entitled to exercise this Warrant on an exercise date in connection with that number of shares of Common Stock which would be in excess of the sum of (i) the number of shares of Common Stock beneficially owned by the Warrant Holder and its affiliates on an exercise date, and (ii) the number of shares of Common Stock issuable upon the exercise of this Warrant with respect to which the determination of this limitation is being made on an exercise date, which would result in beneficial ownership by the Warrant Holder and its affiliates of more than 4.99% of the outstanding shares of Common Stock on such date.  For the purposes of the immediately preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and Regulation 13d-3 thereunder.  Subject to the foregoing, the Warrant Holder shall not be limited to aggregate exercises, which would result in the issuance of more than 4.99%.  The restriction described in this paragraph may be revoked upon sixty-one (61) days prior notice from the Warrant Holder to the Company.  The Warrant Holder may allocate which of the equity of the Company deemed beneficially owned by the Subscriber shall be included in the 4.99% amount described above and which shall be allocated to the excess above 4.99%.

2.

Adjustment of Exercise Price and Number of Shares.  Until the first to occur of the third anniversary of the date hereof or when the aggregate number of common shares underlying any outstanding Preferred Stock and Warrants equal three hundred thousand (300,000) shares or less the character of the shares of stock or other securities at the time issuable upon exercise of this Warrant and the Exercise Price therefore, are subject to adjustment upon the occurrence of the following events, and all such adjustments shall be cumulative:

a.

Adjustment for Stock Splits, Stock Dividends, Recapitalizations, Etc.  The Exercise Price of this Warrant and the number of shares of Common Stock or other securities at the time issuable upon exercise of this Warrant shall be appropriately adjusted to reflect any stock dividend, stock split, combination of shares, reclassification, recapitalization or other similar event affecting the number of outstanding shares of stock or securities except for newly issued options, warrants and shares to Company’s management, employees and consultants up to five (5) percent of fully diluted outstanding shares each year and any other stock issued for valid consideration.

b.

Adjustment for Reorganization, Consolidation, Merger, Etc.  In case of any consolidation or merger of the Company with or into any other corporation, entity or person, or any other corporate reorganization, in which the Company shall not be the continuing or surviving entity of such consolidation, merger or reorganization (any such transaction being hereinafter referred to as a "Reorganization"), then, in each case, the holder of this Warrant, on exercise hereof at any time after the consummation or effective date of such Reorganization (the "Effective Date"), shall receive, in lieu of the shares of stock or other securities at any time issuable upon the exercise of the Warrant issuable on such exercise prior to the Effective Date, the stock and other securities and property (including cash) to which such holder would have been entitled upon the Effective Date if such holder had exercised this Warrant immediately prior thereto (all subject to further adjustment as provided in this Warrant).

a.

Certificate as to Adjustments.  In case of any adjustment or readjustment in the price or kind of securities issuable on the exercise of this Warrant, the Company will promptly give written notice thereof to the holder of this Warrant in the form of a certificate, certified and confirmed by the Board of Directors of the Company, setting forth such adjustment or readjustment and showing in reasonable detail the facts upon which such adjustment or readjustment is based.

b.

The Company fails to meet certain EBIDTA per share projections.   Absent acts of God or other force majuere acts, in the event that the Company fails to meet an annual EBITDA requirement of $0.25 per share for fiscal year 2005 the warrant exercise price shall be reduced proportionately by 0% if the EBIDTA earnings are $0.25 per share and by 90% if the EBIDTA earnings are $0.025 per share. For example, if the Company earns $0.20 per share, or 20% below $0.25 per share, then the warrant exercise price shall be reduced by 20%. Such reduction shall be made at the time the December 31st, 2005 financial results are reported and shall be made from the starting exercise price of the warrants being the exercise price of the warrants at that time, and shall be cumulative upon any other changes to the exercise price of the warrant that may already have been made. In the event the Company earns below $.025, or has a loss, the warrant exercise price shall be reduced by 90%.  EBITDA is defined as net income, from recurring operations before any non-recurring items, as reported on Company’s 10-KSB for the fiscal year ending December 31, 2005 plus interest expense, taxes, depreciation and amortization divided by sum of the of i. Company’s outstanding common shares and ii. preferred shares owned by Barron Partners LP.). 

c.

The Company sells, grants or issues any shares, options, 

warrants, or any instrument convertible into shares or equity in any form below $1.00 per share.   In the event that Company sells, grants or issues any shares, options, warrants, or any instrument convertible into shares or equity in any form below $1.00 per share the warrant exercise price shall be reduced proportionately except for newly issued options, warrants and shares to Company’s management, employees and consultants up to five (5) percent of fully diluted outstanding shares each year. For example, if the Company sells, grants or issues any shares, options, warrants, or any instrument convertible into shares or equity in any form at $.80 per share, or 20% below $1.00 per share, then the warrant exercise price shall be reduced by 20%. Such reduction shall be made at the time such transaction is made, and shall be cumulative upon any other changes to the exercise of the warrant that may already have been made.

1.

Call by the Company.  If, during the period from date of six months and one day after the date of initial issuance of this Warrant to expiration date of the Warrant, the closing public market price of the Company’s common stock is equal to or in excess of $3.00 for a period of twenty (20) consecutive Trading Days and there is an effective Registration Statement covering the shares of Common Stock underlying this Warrant (“Automatic Exercise”) during such twenty (20) consecutive day period, the Company shall provide the Holder with notice of such Automatic Conversion (“Automatic Exercise Notice”).  Upon receipt of the Automatic Exercise Notice, the Holder must (i) exercise, in whole, this Warrant within forty-five (45) days; or (ii) notify the Company of its intent to transfer this Warrant pursuant to Section 4 of this Warrant.  In the event Holder elects to transfer this Warrant pursuant to Section 4 of this Warrant, then the subsequent holder of this Warrant must exercise this Warrant on or before the forty-fifth  (45) day after notification of intent to transfer this Warrant.  In the event that this Warrant is exercised, the Holder must deliver to the Company at its office at 445 Hamilton Avenue, Suite 408, White Plains, New York 10601 on or before 5:00 p.m., Eastern Time, on the required date, (i) Form of Election to Purchase properly executed and completed by Holder or an authorized officer thereof, (ii) a check payable to the order of the Company, in an amount equal to the product of the Exercise Price multiplied by the number of Warrant Shares specified in the Exercise Notice, and (iii) this Warrant.  If the Holder does not exercise this Warrant within forty-five (45) days from receipt of the Automatic Exercise Notice or, in the event that this Warrant has been transferred pursuant to Section 4 of this Warrant, the subsequent holder of this Warrant does not exercise this Warrant within 45 (45) days after notification of intent to transfer this Warrant, then this Warrant will expire.

2.

Fractional Shares.  The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the exercise of this Warrant.  The number of full Warrant Shares that shall be issuable upon the exercise of this Warrant shall be computed on the basis of the aggregate number of Warrants Shares purchasable on exercise of this Warrant so presented.  If any fraction of a Warrant Share would, except for the provisions of this Section 8, be issuable on the exercise of this Warrant, the Company shall, at its option, (i) pay an amount in cash equal to the Exercise Price multiplied by such fraction or (ii) round the number of Warrant Shares issuable, up to the next whole number.

3.

Sale or Merger of the Company.  In the event of a sale of all or substantially all of the assets of the Company or the merger or consolidation of the Company in a transaction in which the Company is not the surviving entity, the 4.99% restriction will immediately be released and the Warrant Holder will have the right to exercise the warrants concurrent with the sale.

4.

Notice of Intent to Sell or Merge the Company.  The Company will give Warrant Holder 62 days notice prior to the closing of an event or transaction that results in the sale of all or substantially all of the assets of the Company or the merger or consolidation of the Company in a transaction in which the Company is not the surviving entity.

5.

Notice.  All notices and other communications hereunder shall be in writing and shall be deemed to have been given (i) on the date they are delivered if delivered in person; (ii) on the date initially received if delivered by facsimile transmission followed by registered or certified mail confirmation; (iii) on the date delivered by an overnight courier service; or (iv) on the third business day after it is mailed by registered or certified mail, return receipt requested with postage and other fees prepaid as follows:

If to the Company:

Cordia Corporation

Attn:  Legal Counsel

445 Hamilton Avenue, Suite 408

White Plains, New York 10601

If to the Warrant Holder:

Andrew Barron Worden

Managing Partner

Barron Partners LP

730 Fifth Avenue, 9th Floor

New York NY 10019

Tel: 212-659-7790

6.

Miscellaneous.

a.  This Warrant shall be binding on and inure to the benefit of the parties hereto and their respective successors and permitted assigns.  This Warrant may be amended only in writing and signed by the Company and the Warrant Holder.

b.  Nothing in this Warrant shall be construed to give to any person or corporation other than the Company and the Warrant Holder any legal or equitable right, remedy or cause of action under this Warrant; this Warrant shall be for the sole and exclusive benefit of the Company and the Warrant Holder.

c. This Warrant shall be governed by, construed and enforced in accordance with the internal laws of the State of Nevada without regard to the principles of conflicts of law thereof.

d.  The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the provisions hereof.

e. In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonably substitute therefore, and upon so agreeing, shall incorporate such substitute provision in this Warrant.

f.  The Warrant Holder shall not, by virtue hereof, be entitled to any voting or other rights of a shareholder of the Company, either at law or equity, and the rights of the Warrant Holder are limited to those expressed in this Warrant.

IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by the authorized officer as of the date first above stated.

Cordia Corporation

By:  /s/  Wesly Minella

Name:  Wesly Minella

Title:  Secretary

FORM OF ELECTION TO PURCHASE

(To be executed by the Warrant Holder to exercise the right to purchase shares of Common Stock under the foregoing Warrant)

To:  CORDIA CORPORATION

In accordance with the Warrant enclosed with this Form of Election to Purchase, the undersigned hereby irrevocably elects to purchase ______________ shares of Common Stock (“Common Stock”), $0.001 par value, of Cordia Corporation and encloses one warrant and $4.00 for each Warrant Share being purchased or an aggregate of $________________ in cash or certified or official bank check or checks, which sum represents the aggregate Exercise Price (as defined in the Warrant) together with any applicable taxes payable by the undersigned pursuant to the Warrant.

The undersigned requests that certificates for the shares of Common Stock issuable upon this exercise be issued in the name of:

(Please print name and address)

(Please insert Social Security or Tax Identification Number)

If the number of shares of Common Stock issuable upon this exercise shall not be all of the shares of Common Stock which the undersigned is entitled to purchase in accordance with the enclosed Warrant, the undersigned requests that a New Warrant (as defined in the Warrant) evidencing the right to purchase the shares of Common Stock not issuable pursuant to the exercise evidenced hereby be issued in the name of and delivered to:

(Please print name and address)

Dated:  

Name of Warrant Holder:

(Print) 

(By:)  

(Name:)  

(Title:)  

Signature must conform in all respects to name of

 

Warrant Holder as specified on the face of the

WarrantExhibit 10.12

                                                      SILGAN HOLDINGS INC.

Anthony J. Allott                                     4 Landmark Square
Executive Vice President and                          Suite 400
Chief Financial Officer                               Stamford, CT  06901

                                                      Telephone: (203) 975-7110
                                                      Fax: (203) 975-7902
                                                      email: tallott@silgan.com
June 30, 2004

Mr. Robert B. Lewis
55 Tanners Drive
Wilton, CT

Dear Bob:

     We are very  pleased  to make  the  following  offer to you to join  Silgan
Holdings Inc.  Beginning on your start date, you will be employed on a full-time
at will basis by Silgan  Holdings Inc.,  serving as its Executive Vice President
and Chief  Financial  Officer.  Additionally,  you will  serve as an  officer of
various subsidiaries of Silgan Holdings Inc. You will report to the President of
Silgan Holdings Inc. Your employment start date will be mutually determined, but
will be no later than August 16, 2004.

     While you are employed by Silgan  Holdings Inc., as  compensation  for your
services, Silgan Holdings Inc. will pay you a salary, which for 2004 shall be at
an annual rate of $400,000.  Your salary  shall be payable to you in  accordance
with the prevailing  payroll  practices  (including the withholding of taxes) of
Silgan  Holdings Inc. Your salary shall be subject to increase at the discretion
of the Compensation Committee of the Board of Directors of Silgan Holdings Inc.

     While you are employed by Silgan  Holdings Inc., you shall also be eligible
to  receive an annual  bonus for each year (pro rated for 2004),  payable in the
following year in accordance with Silgan Holdings  Inc.'s  practices  (including
the withholding of taxes),  in an amount up to a maximum of thirty percent (30%)
of your annual salary for that year. Your bonus for any year shall be payable to
you on the same basis that annual bonuses are payable to the Co-Chief  Executive
Officers and President of Silgan  Holdings Inc. for such year under and based on
the Silgan Holdings Inc. Senior Executive Performance Plan. For 2004, bonuses in
an amount  equal to the  applicable  maximum  amount are payable to the Co-Chief
Executive Officers and President of Silgan Holdings Inc. under and based on such
plan if Silgan  Holdings  Inc.  achieves  EBITDA (as defined in such plan) of at
least the amount of EBITDA of Silgan Holdings Inc. for 2003.

     During your  employment  with Silgan Holdings Inc., you will be entitled to
(i) receive  health and welfare  benefits that are made  available  generally to
employees of Silgan  Holdings  Inc.,  with the full cost for such benefits to be
borne  by  you,  and  (ii)  to  participate  in  the  401(K)  savings  plan  and
supplemental   savings  plan  that  other  employees  of  Silgan  Holdings  Inc.
participate in, subject to the rules and policies thereof,  except that you will
not be entitled to any matching  contributions in respect of your  contributions
to such 401(K) savings plan or

<PAGE>
Mr. Robert B. Lewis                      -2-                       June 30, 2004

supplemental  savings  plan.  The  health  and  welfare  benefits  that are made
available  generally to employees of Silgan Holdings Inc. currently consist of a
comprehensive  medical plan, a long-term disability plan and a supplemental life
plan,  under all of which you would be covered on the first  month after 90 days
of full-time employment.

     Pursuant to the Silgan  Holdings  Inc. 2004 Stock  Incentive  Plan, on your
start date you will be granted (i) 25,000  restricted stock units,  representing
an equivalent number of shares of common stock of Silgan Holdings Inc., and (ii)
non-qualified  options  to  purchase  20,000  shares of  common  stock of Silgan
Holdings  Inc.  The  restricted  stock units will vest  ratably over a five-year
period  beginning  one year after your start date.  The  exercise  price for the
options will be the average of the high and low sales prices of the common stock
of Silgan  Holdings Inc. on your start date, as reported by the Nasdaq  National
Market  System.  Subject to the terms of the Stock  Incentive  Plan, the options
will vest ratably over a five-year  period  beginning  one year after your start
date and will have a term of seven years.

     You will be  entitled to three weeks paid  vacation in 2004  (prorated  for
2004  based  on your  start  date).  Thereafter,  you will be  entitled  to paid
vacation annually in accordance with the policies of Silgan Holdings Inc.

     Other than as set forth above,  you shall not be entitled to participate in
any other benefit plans of, or receive any other benefits from,  Silgan Holdings
Inc.  or any of its  subsidiaries,  including,  without  limitation,  under  any
pension  plan,  except  that you shall be entitled  to also  participate  in and
receive  benefits under any stock option,  restricted stock or other stock based
compensation plan in which other officers of Silgan Holdings Inc. participate.

     In the event that your  employment  with Silgan Holdings Inc. is terminated
without cause by Silgan  Holdings  Inc.,  you will be entitled to receive a lump
sum severance payment in an amount equal to the sum of (i) your annual salary at
such time plus (ii) your annual  bonus,  calculated  at thirty  percent (30%) of
your annual salary at such time.

     Please understand that this letter  constitutes only an offer of employment
and  is  contingent  upon  satisfactory  results  of a  pre-placement  physical,
including  a drug  screen,  to be  completed  prior to your  start  date  with a
physician  of our choice and at the expense of Silgan  Holdings  Inc.,  and upon
approval by the Board of Directors of Silgan Holdings Inc. and its  Compensation
Committee.

     We very much look forward to you joining us at Silgan Holdings Inc.

Sincerely,

/s/ Anthony J. Allott
---------------------
Anthony J. Allott

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}]]